Ponesimod

Ponesimod, sold under the brand name Ponvory, is a medication for the treatment of multiple sclerosis (MS).[1][5] The most common side effects include upper respiratory tract infection, hepatic transaminase elevation, and hypertension.[1][5] Ponesimod was approved for medical use in the United States in March 2021[1][5] and in the European Union in June 2021.[6] Contents 1 Clinica... [wikipedia]